You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Moodys
Harvard Business School
Boehringer Ingelheim
Express Scripts

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 8,083,620

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,083,620
Title:Ball bats
Abstract: Ball bats comprising a stem and a handle surrounding the stem. An elastomeric decoupler system installed in the handle sharply reduces the transmission of shocks and vibrations from the stem to the handle, mitigating stinging and other unpleasant sensations experienced by the batter when a ball is struck. Unpleasant sensations can be further reduced by installing a DTMS damping device in the knob of the bat and by installing an elastomeric grip on the handle of the bat; and the unpleasant sound made when a bat strikes the ground or the like can be materially reduced by a device attached to the stem of the bat intermediate the ends of the handle. The present inventions are particularly adaptable to hollow, metal bats; and provision is made for venting the knob of the bat when it is welded in place so hot gases will not be forced into, and reduce the integrity of, the weld. Appropriate ones of the devices described above may also advantageously be employed in wood, composite, and other bats.
Inventor(s): Sims; Steven C. (Shelton, WA), Sims; Gary (Shelton, WA), Winters; Greg (Shelton, WA), Seil; Jonathan F. (Shelton, WA)
Assignee: Sims Vibration Laboratory, Inc. (Shelton, WA)
Application Number:13/066,109
Patent Claims:see list of patent claims

Details for Patent 8,083,620

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Sims Vibration Laboratory, Inc. (Shelton, WA) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Moodys
Merck
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.